Patents by Inventor Kihang Choi

Kihang Choi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8871718
    Abstract: Transglutaminase inhibitors and methods of use thereof are provided.
    Type: Grant
    Filed: December 4, 2012
    Date of Patent: October 28, 2014
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Chaitan Khosla, Richard Edward Watts, Matthew John Siegel, Kihang Choi
  • Patent number: 8604230
    Abstract: Disclosed does a porous crystal comprising ammonia borane in which the ammonia borane is chemically bonded thereto by a chemical reaction while a porous crystal structure is maintained.
    Type: Grant
    Filed: August 13, 2010
    Date of Patent: December 10, 2013
    Assignee: Insilicotech Co., Ltd
    Inventors: Donghyun Jung, Junho Kim, Minkyoung Kim, Daejin Kim, Seunghoon Choi, Kihang Choi, Jaheon Kim, Kyungseok Jeong, Sangbeom Choi, Nakeun Ko
  • Patent number: 8470782
    Abstract: Transglutaminase inhibitors and methods of use thereof are provided.
    Type: Grant
    Filed: August 28, 2006
    Date of Patent: June 25, 2013
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Chaitan Khosla, Richard Edward Watts, Matthew John Siegel, Daniel M. Pinkas, Kihang Choi, Keith M. Rich
  • Publication number: 20120016146
    Abstract: Disclosed does a porous crystal comprising ammonia borane in which the ammonia borane is chemically bonded thereto by a chemical reaction while a porous crystal structure is maintained.
    Type: Application
    Filed: August 13, 2010
    Publication date: January 19, 2012
    Applicant: INSILICOTECH CO., LTD
    Inventors: Donghyun Jung, Junho Kim, Minkyoung Kim, Daejin Kim, Seunghoon Choi, Kihang Choi, Jaheon Kim, Kyungseok Jeong, Sangbeom Choi, Nakeun Ko
  • Publication number: 20110286995
    Abstract: Administering an effective dose of a tTGase inhibitor to a Celiac or dermatitis herpetiformis patient reduces the toxic effects of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
    Type: Application
    Filed: June 13, 2011
    Publication date: November 24, 2011
    Inventors: CHAITAN KHOSLA, KIHANG CHOI
  • Publication number: 20090312272
    Abstract: Transglutaminase inhibitors and methods of use thereof are provided.
    Type: Application
    Filed: August 4, 2009
    Publication date: December 17, 2009
    Inventors: Chaitan Khosla, Richard Edward Watts, Matthew John Siegel, Daniel M. Pinkas, Kihang Choi, Keith M. Rich
  • Patent number: 7579313
    Abstract: Transglutaminase inhibitors and methods of use thereof are provided.
    Type: Grant
    Filed: August 26, 2005
    Date of Patent: August 25, 2009
    Assignees: The Board of Trustees of the Leland Stanford Junior University, The Washington University
    Inventors: Chaitan Khosla, Richard Edward Watts, Matthew John Siegel, Daniel M. Pinkas, Kihang Choi, Keith M. Rich
  • Publication number: 20090042806
    Abstract: Transglutaminase inhibitors and methods of use thereof are provided.
    Type: Application
    Filed: August 28, 2006
    Publication date: February 12, 2009
    Inventors: Chaitan Khosla, Richard Edward Watts, Matthew John Siegel, Daniel M. Pinkas, Kihang Choi, Keith M. Rich
  • Publication number: 20080233102
    Abstract: Administering an effective dose of a tTGase inhibitor to a Celiac or dermatitis herpetiformis patient reduces the toxic effects of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
    Type: Application
    Filed: November 12, 2004
    Publication date: September 25, 2008
    Inventors: Chaitan Khosla, Kihang Choi
  • Publication number: 20080044401
    Abstract: Administering an effective dose of a tTGase inhibitor to a Celiac or dermatitis herpetiformis patient reduces the toxic effects of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
    Type: Application
    Filed: August 28, 2007
    Publication date: February 21, 2008
    Inventors: Chaitan Khosla, Kihang Choi
  • Patent number: 7265093
    Abstract: Administering an effective dose of a tTGase inhibitor to a Celiac or dermatitis herpetiformis patient reduces the toxic effects of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
    Type: Grant
    Filed: November 18, 2003
    Date of Patent: September 4, 2007
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Chaitan Khosla, Kihang Choi
  • Publication number: 20060052308
    Abstract: Transglutaminase inhibitors and methods of use thereof are provided.
    Type: Application
    Filed: August 26, 2005
    Publication date: March 9, 2006
    Inventors: Chaitan Khosla, Richard Watts, Matthew Siegel, Daniel Pinkas, Kihang Choi, Keith Rich
  • Publication number: 20040167069
    Abstract: Administering an effective dose of a tTGase inhibitor to a Celiac or dermatitis herpetiformis patient reduces the toxic effects of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
    Type: Application
    Filed: November 18, 2003
    Publication date: August 26, 2004
    Inventors: Chaitan Khosla, Kihang Choi